VitaNova Life Sciences Corporation Increase (Decrease) in Accounts Payable and Accrued Liabilities
VitaNova Life Sciences Corporation (VNOV) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $7.37 thousand for the 3-month period ending 2025-07-31, per its 10-Q filed 2025-09-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2025-09-12
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-07-31 was $7.37K, a 13.32% increase year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-04-30 was -$14.19K, a 234.49% decline year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-01-31 was $2.49K.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-10-31 was $1.00, a 99.87% decline year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$5.19K, a 158.28% decline from fiscal 2024.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $8.91K, a 52.19% increase from fiscal 2023.
- VitaNova Life Sciences Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $5.85K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-07-31 | $7.37K 10-Q · filed 2025-09-12 | -$6.82K derived: sum of 2 quarters · filed 2025-09-12 | -$4.33K derived: sum of 3 quarters · filed 2025-09-12 | -$4.32K derived: sum of 4 quarters · filed 2025-09-12 |
| 2025-04-30 | -$14.19K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | -$11.69K derived: sum of 2 quarters · filed 2025-07-24 | -$11.69K derived: sum of 3 quarters · filed 2025-07-24 | -$5.19K 10-K · filed 2025-07-24 |
| 2025-01-31 | $2.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $2.50K derived: sum of 2 quarters · filed 2025-03-17 | $8.99K 10-Q · filed 2025-03-17 | $19.54K derived: sum of 4 quarters · filed 2025-09-12 |
| 2024-10-31 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | $6.50K 10-Q · filed 2024-12-13 | $17.05K derived: sum of 3 quarters · filed 2025-09-12 | $16.54K derived: sum of 4 quarters · filed 2025-09-12 |
| 2024-07-31 | $6.50K 10-Q · filed 2025-09-12 | $17.05K derived: sum of 2 quarters · filed 2025-09-12 | $16.54K derived: sum of 3 quarters · filed 2025-09-12 | $17.31K derived: sum of 4 quarters · filed 2025-09-12 |
| 2024-04-30 | $10.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $10.04K derived: sum of 2 quarters · filed 2025-07-24 | $10.81K derived: sum of 3 quarters · filed 2025-07-24 | $8.91K 10-K · filed 2025-07-24 |
| 2024-01-31 | -$505.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $259.00 derived: sum of 2 quarters · filed 2025-03-17 | -$1.64K 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $764.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | -$1.14K 10-Q · filed 2024-12-13 | ||
| 2023-07-31 | -$1.90K 10-Q · filed 2024-09-10 | |||
| 2023-04-30 | $5.85K 10-K · filed 2024-07-29 |